A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT00002337 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2005-06-24
Summary
To evaluate the safety and tolerability of four doses of oral vesnarinone in patients with advanced HIV disease.
Conditions
- HIV Infections
Interventions
- DRUG
-
Vesnarinone
Sponsors & Collaborators
-
Otsuka America Pharmaceutical
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients
NCT03164447 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection
NCT00002119 ·Status: COMPLETED ·Phase: PHASE1
-
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002035 ·Status: COMPLETED ·Phase: NA
-
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
NCT03407105 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers
NCT00821535 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of Brentuximab Vedotin in Participants With HIV
NCT05244473 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
NCT00001002 ·Status: COMPLETED ·Phase: PHASE1
-
ODYSSEY (PENTA 20)
NCT02259127 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
NCT00002312 ·Status: COMPLETED ·Phase: NA
-
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
NCT00000692 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002338 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy
NCT05612178 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
NCT00082498 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E
NCT00002094 ·Status: COMPLETED ·Phase: NA
-
A Study of DPC 817 in HIV-Infected Males
NCT00040274 ·Status: COMPLETED ·Phase: PHASE1
-
Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects
NCT00352911 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
NCT00002244 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
NCT00002087 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
NCT00046332 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
NCT00002385 ·Status: COMPLETED ·Phase: NA
-
Study of Itraconazole in Patients With Advanced HIV Infection
NCT00002370 ·Status: COMPLETED ·Phase: NA
-
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
NCT00002311 ·Status: COMPLETED ·Phase: PHASE1
-
First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy Participants
NCT05393271 ·Status: COMPLETED ·Phase: PHASE1